Parabilis Medicines is a clinical-stage biopharmaceutical company creating groundbreaking therapies by targeting previously undruggable biological pathways. They have developed Helicon™ peptides, a novel class of alpha-helical peptides, which are engineered to modulate intracellular proteins effectively. With a focus on diseases driven by the Wnt/β-catenin pathway, their lead candidate, zolucatetide, represents a unique solution for patients facing serious health challenges.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →